ERBB4 and Sepsis: Next, miR‐146a inhibits sepsis‐induced myocardial dysfunction by targeting ErbB4 (An, Feng, Xi, Xu, & Sun, 2018), and miR‐21‐3p modulates sepsis‐induced cardiac dysfunction by targeting SORBS2 (Wang et al., 2016).